The value of genome-wide association studies and genetic risk scales for predicting type 2 diabetes mellitus, its complications, and pharmacogenetics
Open Access
- 24 May 2025
- journal article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 6,p. 67-74
Abstract
Type 2 diabetes (T2D) is a complex, heritable metabolic disorder characterized by dysregulated glucose homeostasis arising from impaired insulin secretion and insulin resistance. Genome-wide association studies (GWAS) have successfully pinpointed hundreds of genetic loci associated with type 2 diabetes risk, implicating numerous genes in its pathogenesis. Genetic risk assessment can help to predict disease progression and identify at-risk populations where preventive interventions, including lifestyle modification, could be more effective. In addition, identification of patients at high risk of developing T2D will allow for earlier diagnosis and effective treatment at the stage of minimal disorders of carbohydrate metabolism. Better understanding of the pathogenesis of the disease based on knowledge of the functions of genes associated with T2D may help in the development of new drugs to control carbohydrate metabolism. In perespective, the translation of genetic data into clinical applications holds immense potential for advancing type 2 diabetes management, including the development of novel therapeutics and risk prediction strategies. This review explores recent advances in the genomics of type 2 diabetes, highlighting ongoing initiatives to promote precision health. We discuss the use of genetic data in predicting the risk of developing diabetes and its complications, as well as in predicting individual responses to medications and lifestyle interventions.Keywords
This publication has 41 references indexed in Scilit:
- Dorzagliatin: First ApprovalDrugs, 2022
- Personalised prevention of type 2 diabetesDiabetologia, 2022
- Genetics of Type 2 Diabetes: Implications from Large-Scale StudiesCurrent Diabetes Reports, 2022
- Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose controlDiabetologia, 2021
- Diabetes and Genetics: A Relationship Between Genetic Risk Alleles, Clinical Phenotypes and Therapeutic Approaches2020
- The Genetic Epidemiology of Type 2 Diabetes: Opportunities for Health TranslationCurrent Diabetes Reports, 2019
- Genome-wide association study for sight-threatening diabetic retinopathy reveals association with genetic variation near the GRB2 geneDiabetologia, 2015
- A genome‐wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic painEuropean journal of pain, 2015
- Bridging the Gap Between Genetic Associations and Molecular Mechanisms for Type 2 DiabetesCurrent Diabetes Reports, 2013
- Association Between a Genetic Variant Related to Glutamic Acid Metabolism and Coronary Heart Disease in Individuals With Type 2 DiabetesJAMA, 2013